Items where Author is "Avan, A."
![]() | Up a level |
(2024) Microbiome as a biomarker and therapeutic target in pancreatic cancer. Bmc Microbiology. p. 24. ISSN 1471-2180
(2024) The burden of neurological conditions in north Africa and the Middle East, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet Global Health. E960-E982. ISSN 2214-109X
(2024) The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer. Molecular and Cellular Biochemistry. pp. 1243-1255. ISSN 1573-4919 (Electronic) 0300-8177 (Linking)
(2023) Bioactive Peptides: Potential Impact on the Treatment of Gastrointestinal Cancers. Current Pharmaceutical Design. pp. 2450-2460. ISSN 1381-6128
(2023) Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019. Frontiers in Public Health. ISSN 22962565 (ISSN)
(2021) Inhibition of Transforming Growth Factor-Beta by Tranilast Reduces Tumor Growth and Ameliorates Fibrosis in Colorectal Cancer. Excli Journal. pp. 601-613. ISSN 1611-2156
(2019) High dose vitamin D supplementation is associated with an improvement in serum markers of liver function. Biofactors. pp. 335-342. ISSN 1872-8081 (Electronic) 0951-6433 (Linking)
(2018) Evaluation of miR-21 Inhibition and its Impact on Cancer Susceptibility Candidate 2 Long Noncoding RNA in Colorectal Cancer Cell Line. Adv Biomed Res. p. 14. ISSN 2277-9175 (Print) 2277-9175 (Linking)
(2017) Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Cancer Gene Therapy. pp. 48-56. ISSN 0929-1903
(2017) Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer. Journal of Cellular Biochemistry. pp. 4129-4140. ISSN 0730-2312
(2017) Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4. Tumor Biology. ISSN 1010-4283
(2016) Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents. Current Medicinal Chemistry. pp. 455-463. ISSN 0929-8673
(2016) Association between serum cytokine concentrations and the presence of hypertriglyceridemia. Clinical Biochemistry. pp. 750-755. ISSN 0009-9120
(2016) The Association of High Risk Human Papillomaviruses in Patients With Cervical Cancer: An Evidence Based Study on Patients With Squamous Cell Dysplasia or Carcinoma for Evaluation of 23 Human Papilloma Virus Genotypes. Jundishapur Journal of Microbiology. ISSN 2008-3645
(2016) Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives. Current Medicinal Chemistry. pp. 4135-4150. ISSN 0929-8673
(2016) Deciphering biological characteristics of tumorigenic subpopulations in human colorectal cancer reveals cellular plasticity. Journal of Research in Medical Sciences. ISSN 1735-1995
(2016) Early detection of colorectal cancer: from conventional methods to novel biomarkers. Journal of Cancer Research and Clinical Oncology. pp. 341-351. ISSN 0171-5216
(2016) Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach. Cancer Gene Therapy. pp. 246-253. ISSN 0929-1903
(2016) The Potential for Circulating microRNAs in the Diagnosis of Myocardial Infarction: A Novel Approach to Disease Diagnosis and Treatment. Current Pharmaceutical Design. pp. 397-403. ISSN 1381-6128